Doximity (NYSE:DOCS) Lowered to Strong Sell Rating by Zacks Research

Posted by Brenda Bartman on Jun 4th, 2026

Zacks Research downgraded shares of Doximity (NYSE:DOCS – Free Report) from a hold rating to a strong sell rating in a research report sent to investors on Tuesday,Zacks.com reports.

DOCS has been the topic of several other research reports. Mizuho dropped their target price on shares of Doximity from $34.00 to $26.00 and set a “neutral” rating on the stock in a research report on Thursday, May 14th. Canaccord Genuity Group dropped their target price on shares of Doximity from $34.00 to $30.00 and set a “buy” rating on the stock in a research report on Thursday, May 14th. Jefferies Financial Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and dropped their target price for the stock from $51.00 to $19.00 in a research report on Thursday, May 14th. BMO Capital Markets dropped their target price on shares of Doximity from $25.00 to $20.00 and set a “market perform” rating on the stock in a research report on Thursday, May 14th. Finally, Piper Sandler boosted their target price on shares of Doximity from $40.00 to $42.00 and gave the stock an “overweight” rating in a research report on Friday, February 20th. Two analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, Doximity presently has a consensus rating of “Hold” and a consensus target price of $30.62.

Read Our Latest Report on Doximity

Doximity Stock Performance

NYSE:DOCS opened at $21.09 on Tuesday. The stock has a market cap of $3.86 billion, a P/E ratio of 21.30, a PEG ratio of 3.66 and a beta of 1.30. Doximity has a twelve month low of $17.15 and a twelve month high of $76.51. The stock’s 50 day moving average is $22.78.

Doximity announced that its Board of Directors has approved a stock repurchase plan on Thursday, February 5th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to purchase up to 8% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its stock is undervalued.

Insider Activity at Doximity

In other Doximity news, insider Siddharth Sitaram sold 2,309 shares of Doximity stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $25.77, for a total transaction of $59,502.93. Following the completion of the sale, the insider directly owned 89,396 shares in the company, valued at approximately $2,303,734.92. The trade was a 2.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Kira Scherer Wampler sold 9,000 shares of Doximity stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $26.06, for a total transaction of $234,540.00. Following the sale, the director owned 19,839 shares of the company’s stock, valued at approximately $517,004.34. The trade was a 31.21% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 16,055 shares of company stock valued at $404,061. Company insiders own 31.30% of the company’s stock.

Institutional Investors Weigh In On Doximity

A number of hedge funds have recently modified their holdings of the business. Parallel Advisors LLC raised its position in shares of Doximity by 111.0% in the first quarter. Parallel Advisors LLC now owns 2,560 shares of the company’s stock valued at $60,000 after buying an additional 1,347 shares during the last quarter. Essential Partners LLC grew its holdings in shares of Doximity by 34,438.5% in the first quarter. Essential Partners LLC now owns 8,980 shares of the company’s stock valued at $209,000 after purchasing an additional 8,954 shares during the period. Bank of America Corp DE grew its holdings in shares of Doximity by 31.8% in the first quarter. Bank of America Corp DE now owns 1,142,530 shares of the company’s stock valued at $26,621,000 after purchasing an additional 275,650 shares during the period. Edgestream Partners L.P. grew its holdings in shares of Doximity by 110.8% in the first quarter. Edgestream Partners L.P. now owns 252,555 shares of the company’s stock valued at $5,885,000 after purchasing an additional 132,733 shares during the period. Finally, Amundi grew its holdings in shares of Doximity by 9,956.5% in the first quarter. Amundi now owns 569,095 shares of the company’s stock valued at $13,260,000 after purchasing an additional 563,436 shares during the period. 87.19% of the stock is currently owned by institutional investors and hedge funds.

About Doximity

(Get Free Report)

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.